home : about us : e-mail   
 
 
 
Varicella-zoster virus  


Varicella rash (WHO photo)

Varicella-zoster virus (VZV) is a member of the herpes virus group, (alpha) herpes virus 3. It is a DNA virus

Primary VZV often causes the disease known as chickenpox. Chickenpox can be severe and have a number of complications. After a primary infection, the virus enters the sensory nerves and becomes latent in the dorsal root ganglia along with spinal column. Decades later the virus may reactivate and moves down the same nerve, to cause the disease known as shingles. Thus, shingles is the same virus that was first acquired 20-40 year earlier.

Prior to 1998, the dogma among virologists was that VZV had only minimal diversity around the world. In other words, VZV was the same virus in the United States, the United Kingdom, India, Thailand or Japan. Similarly, VZV was considered to be the same serotype around the world also.

In 1998, the first report was published, which described the discovery of a community VZV strain with a mutation in one of the major surface glycoproteins called gE. The strain was designated VZV-MSP, because it was discovered in the Minneapolis-St. Paul metropolitan area of Minnesota. What is most unusual about this mutant strain is that it has a phenotype that is distinguishable from most other community VZV strains. The altered phenotype relates to patterns of egress. Most community VZV strains emerge from infected cells in a pattern called “viral highways,” long rows of virions across the surface of an infected cell. In contrast, the mutant virus strain VZV-MSP emerges in a uniform pattern over the surface of the infected cell.

The mutant virus has also been tested in the severe combined immunodeficient (SCID-hu) mouse model. In this model, human skin explants are inserted under the skin of the SCID mouse. VZV is then infected into the human skin and subsequently examined after pathological sectioning and staining. When typical community strains were compared with VZV-MSP in the SCID-hu model, it was observed that the mutant virus spread faster. In another assay of cell spread, VZV-MSP spread about 30% faster than most other community strains. Although the SCID-hu model does not measure virulence, the attribute of increased cell spread is compatible with increased virulence.

When VZV-MSP was originally discovered and reported, it was considered by many virologists to be an extraordinarily rare event, perhaps never happening again. However, just four years later, another gE glycoprotein mutant virus was discovered in a 70 year old Canadian man, who had a severe case of shingles on the face. The fact that two gE mutant viruses have been discovered within a few years of one another leads to a startling conclusion. Populations of mutant gE viruses may exist in circumscribed geographic areas in the US and Canada.

In summary, VZV is not the same genotype or the same phenotype around the world. Genetic diversity and phenotypic diversity certainly exist. In future years, by collecting VZV samples from around the world, we will be able to determine the extent of this diversity.

The following web sites contain detailed information regarding Varicella-zoster virus:

CDC varicella web page

Dr. Charles Grose's varicella laboratory web site

National Immunization Program Information on Varicella Vaccine

US states requiring varicella vaccine administration